Twist Bioscience Corporation (TWST) News

Twist Bioscience Corporation (TWST): $42.55

1.44 (+3.50%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add TWST to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#171 of NR

in industry

Filter TWST News Items

TWST News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest TWST News From Around the Web

Below are the latest news stories about TWIST BIOSCIENCE CORP that investors may wish to consider to help them evaluate TWST as an investment opportunity.

Twist Bioscience launches human methylome panel

Twist Bioscience (NASDAQ:TWST) on Tuesday announced the launch of its Human Methylome Panel, a product that can advance applications in cancer metastasis, human development and functional genetics. The company said its Twist Human Methylome Panel can also be used as a discovery tool to identify methylation biomarkers that can then be...

Seeking Alpha | May 31, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!